\

PffitscA
Lle,eqtee*

5"s,2,37

isr:: '#tjiiilijF*ii#t
:;t"firidnieka
L,7-

{iif,4H,*t *c{}.hc, TI-iisFa i=i--fttGtrt-Ea

bl2

a=
Iei ul
iii+J-1t-zt
^taft:1

ReeerE 3?sw*.tF

'

-a

slmdrome screening
=;,:1!:.!=.j
Ana
"5"

27-5

Fe*rses
Fliuin nrinin

at sampli$g dai

.a--,.-J

;ia-a

59 hg

?Yetgnr

iii tsfii;:;: ia?i'ry

trrkns.Yn

Pr*.iioustnsurnY?l

no

Smoking

Caucasian

Fsegancies

Correcied MoM's and caleutated risks

fb-hcG
PAPP-A

n 77

12? nglnl

f\nn

ltlahl

1.94 Con" MoM

rniU/mi

utlra

${JIJ[I[I

fit1?,15

Day of ulira sound

ua:a
O.9O mm

Nuchal transiucencY

A ?n

";-;

!? 7:n
Gestationai ageby CRL

11

Gestation age on the day of serum taking

tlr

la^ll

Nasalbone

ivleasured by

Dr MILENKOVIC

Quaffications in measuring NT

DrMlLEirtKOVtG

Risks at sampling date

&cf trsn4+FlT
'!:S-"1

b#add

Tr*.{ry

*! *; tr"s*pt:itxzr:* st sflRi 3t 3s +? d!4?4Si

The patient combined risk presumes the NT measurernent was cione aecorciing

t8: 5tt-523

'#q& + S$T

<t-tigE$l

&tuF*d

iio accepted

guiddines {Prenai Diagn

{ts-qE}}.
ri*ks have
Tire iaa:cratury *arr l;*t- be ir*:$ re*pe*-rsibie for iireir ffipaci si+ ii risk assessr-nei-ri i *ai*uiaieei
diagnostb vai#e!

I-\-*a
vsls

ai
rsljs'..
v! ramrt'

11t'1"U15

[@Ct*or,k*#tef;qeffi*

r-ro